DEGODS TRADEMARK LICENSE AGREEMENT
Last Updated: December 12, 2023
DownloadWelcome to the DeGods Trademark License Agreement (this
“Agreement”), which is a legally binding contract by and between De
Labs, Inc. (“De Labs”), a Delaware corporation, and each DeGods NFT
Holder (“you” or “Licensee”). It provides the terms and conditions
applicable to the potential use of the DeGods marks (shown here
https://www.ip.de.xyz) (the “Licensed Marks,” as defined below) by
DeGods NFT holders.
By submitting a request to use any Licensed Marks or otherwise using
any Licensed Marks, Licensee acknowledges that Licensee has
carefully read and agrees to be bound by this Agreement.
1. Eligibility.
Any holder of a DeGods NFT (as defined below) who (a) has
completed a request for use of the Licensed Marks and been
approved through the process defined by De Labs in
https://www.ip.de.xyz (the “Website”) and (b) is eligible to
legally conduct business with De Labs under applicable law (e.g.,
you, and the country you reside in, are not subject to sanctions
and of legal contracting age in your jurisdiction), may use the
Licensed Marks but only in strict compliance with this Agreement.
2. License Grant.
Subject to Licensee’s compliance with the terms and conditions of
this Agreement and so long as Licensee owns a DeGods non-fungible
token as recorded on the relevant blockchain (“DeGods NFT”), De
Labs grants to Licensee, and Licensee hereby accepts, a limited,
non-exclusive, worldwide (but only where permitted by law),
revocable, non-transferable, non-sublicensable, royalty-free
license, during the term of this Agreement, to use and reproduce
the trademarks and logos as approved by De Labs in its sole and
absolute discretion and listed on the Website (the “Licensed
Marks”) solely on and in connection with the products and/or
services described in Licensee’s request for use of Licensed Marks
completed via the Website and approved by De Labs or (if
applicable) its Designee in its sole and absolute discretion (the
“Licensed Products”), and for no other purpose. Specifically, the
license granted under this Agreement does not include the right to
use the Licensed Marks to create, or in any other way in
connection with, any non-fungible tokens or other digital
collectible items accounted for on a blockchain network. De Labs
reserves all rights not expressly granted in this Agreement.
3. De Labs’ Designee.
De Labs may from time to time authorize a third party, including a
decentralized autonomous organization (DAO), to approve or reject
requests for use of the Licensed Marks and/or otherwise exercise
certain De Labs’ rights under this Agreement (such third-party, a
“Designee”).
4. Ownership of Licensed Marks.
As between the parties, (i) De Labs owns and will retain all
right, title, and interest in and to the Licensed Marks; and (ii)
all use by Licensee of the Licensed Marks under this Agreement,
and all goodwill accruing therefrom, will inure solely to the
benefit of De Labs. Licensee will not dispute or challenge, or
assist any person or entity in disputing or challenging, De Labs’
rights in and to the Licensed Marks or the Licensed Marks’
validity. If Licensee acquires any rights in the Licensed Marks by
operation of law or otherwise or De Labs requires the execution of
certain documents or other acts to maintain, perfect, or enforce
its rights, Licensee hereby irrevocably: (i) assigns and transfers
such rights to De Labs, along with all associated goodwill; (ii)
agrees to take any further such acts; and (iii) appoints De Labs’
and its Designee’s officers as Licensee’s attorneys in fact,
coupled with an interest, for such limited purpose. Licensee
agrees that it will not register or try to register any trademark
that is confusingly similar to the Licensed Marks anywhere.
Licensee agrees to not use or register any trademark with De Labs’
branding and design elements or any similar branding or design
elements.
5. Compliance.
Licensee agrees that its use of the Licensed Marks and the
Licensed Products will be consistent with De Labs’ quality
standards and brand usage guidelines established from time to
time, and will be in compliance with all applicable laws and
regulations. If De Labs notifies Licensee that Licensee’s use of
the Licensed Marks and/or the Licensed Products falls below De
Labs’ standards, Licensee will fix the problem to De Labs’
satisfaction within thirty (30) days of notice. Licensee will not
use the Licensed Marks in any manner that may defame, disparage,
dilute, tarnish or otherwise damage or harm the reputation of De
Labs, its affiliates or their business, or the Licensed Marks.
6. Licensee’s Name and Marks; Disputes. .
Licensees may be identified in a list of De Labs’ licensees made
publicly available by De Labs (on its website and/or via other
means), and Licensee authorizes De Labs to use Licensee’s name and
marks for such purpose. Licensee acknowledges and agree that the
Licensed Marks may be licensed to third-parties for use in
connection with products or services similar to the Licensed
Products, and De Labs has the right, but has no obligation, to
support the resolution of, or resolve any, dispute that may arise
between licensees of the Licensed Marks, which may include
modifying this Agreement or any approvals previously granted.
7. Term and Termination.
This Agreement remains in effect until terminated. De Labs may
terminate this Agreement on written notice to Licensee, effective
immediately, if (i) Licensee fails to fix any problem with its use
of the Licensed Marks within thirty (30) days after De Labs
provides notice as described in Section 5; (ii) Licensee stops
using the Licensed Marks for at least six (6) months; (iii)
Licensee notifies De Labs that Licensee intends to stop using the
Licensed Marks; (iv) Licensee breaches this Agreement; (v) upon
any Change of Control (defined in Section 9(f)), bankruptcy, or
insolvency of, or appointment of a receiver for, Licensee, in each
case, as determined by De Labs in its reasonable discretion, and
(vi) any actual or attempted assignment or transfer of this
Agreement. Further, this Agreement will automatically terminate if
Licensee ceases to own a DeGods NFT. Upon termination of this
Agreement, Licensee will immediately discontinue all use of the
Licensed Marks, provided that Licensee will be allowed to sell-off
any inventory of physical Licensed Products existing on the date
of termination for a period not to exceed four (4) months after
termination. The provisions of Sections 4, 6, 8 and 10-12 shall
survive the termination or expiration of this Agreement.
8. Confidential Information.
“Confidential Information” means any business or technical
information of either party, including, without limitation, any
information relating to any plans, finances, marketing plans,
customer lists, business opportunities, research, development or
know-how and any other information the nature of which would
reasonably be expected to be proprietary or confidential.
Confidential Information will not include information: (i) in the
public domain through no fault of the receiving party at the time
of disclosure; (ii) rightfully known by the receiving party
without restriction as to use or disclosure prior to receiving
such information; (iii) rightfully acquired by the receiving party
from a third party who has the right to disclose such information
without breach of any obligation of confidentiality; or (iv) that
is independently developed by the receiving party without
reference to Confidential Information of the disclosing party.
The parties will not use the Confidential Information of one
another except as necessary for the performance of this Agreement
and will not disclose such Confidential Information to any third
party. The parties will use all reasonable efforts to maintain
the confidentiality of one another’s Confidential Information, but
in no event less than the efforts that it ordinarily uses with
respect to its own proprietary information of similar importance.
The foregoing obligations will not restrict the parties from
disclosing Confidential Information pursuant to the order or
requirement of a court, administrative agency, or other
governmental body, provided that the parties give reasonable
notice to one another to enable them to contest the order or
requirement.
9. Right of First Refusal .
- . In the event of either (i) a Change of Control (as defined below); or
(ii) any other voluntarily transfer, assignment, conveyance, sale
(other than sales of Licensed Products in the ordinary course of
business), or other disposal of all or any part of Licensee’s business
in respect of the Licensed Products (the “Business”) (clauses (i) and
(ii), collectively, a “Transfer”), Licensee shall first offer De Labs
a right to purchase all or any portion of the Business (the “Offered
Interest”), which right De Labs may elect to exercise in its sole and
absolute discretion.
- . Licensee shall deliver a written notice to De Labs stating (i)
Licensee’s bona fide intention to Transfer the Offered Interest, (ii)
the name and address of the proposed purchasing party of the Offered
Interest, and (iii) the purchase price and terms of payment for which
Licensee proposes to Transfer the Offered Interest.
- . Within sixty (60) days after receipt of the notice described in
Section 9(b), De Labs shall notify Licensee in writing of its desire
to exercise its right to purchase the Offered Interest. The failure
of De Labs to submit a notice within the applicable period shall
constitute an election on the part of De Labs not to purchase the
Offered Interest.
- . Within ninety (90) days after receipt of the notice described in
Section 9(b), De Labs shall have the first right to purchase the
Offered Interest upon the price and terms of payment designated in
such notice. If such notice provides for the payment of non-cash
consideration, De Labs may elect to pay the consideration in cash
equal to the good faith estimate of the present fair market value of
the non-cash consideration offered.
- . If De Labs elects not to purchase the Offered Interest, then Licensee
may transfer the Offered Interest to the proposed purchaser, provided
such Transfer (i) is completed within ninety (90) days after the
expiration of De Labs’ right to purchase the Offered Interest, and
(ii) is made at the price and terms designated in such notice. If the
Offered Interest is not transferred, Licensee must give notice in
accordance with this Section 9 prior to any other or subsequent
transfer of the Offered Interest.
- . “Change of Control” means (i) the sale of all or substantially all of
assets of the Business; (ii) any merger, consolidation or acquisition of
Licensee with, by or into another corporation, entity or person; (iii)
any change in the ownership of more than fifty percent (50%) of the
voting capital stock of Licensee in one or more related transactions; or
(iv) any transfer or disposition of any assets of the Business by
judicial order, foreclosure, legal process, execution, attachment or
other similar procedure or process.
10. Representations and Warranties; Disclaimer.
Each party represents and warrants to the other party that: (i) it has
the right to enter into this Agreement and (ii) the execution,
delivery and performance of this Agreement are within the corporate
powers of such party and have been duly authorized by all necessary
corporate action on the part of such party (if applicable), and this
Agreement constitutes a valid and binding agreement of such party.
EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 10, DE LABS EXPRESSLY
DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS,
IMPLIED, STATUTORY, OR OTHERWISE, IN CONNECTION WITH THIS AGREEMENT
AND THE Y00TS MARKS, INCLUDING ANY WARRANTIES OF TITLE,
NON-INFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR
PURPOSE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, DE LABS
MAKES NO REPRESENTATION OR WARRANTY THAT ANY LICENSED TRADEMARK IS
VALID OR THAT THE EXERCISE BY LICENSEE OF ANY RIGHTS GRANTED UNDER
THIS AGREEMENT WILL NOT INFRINGE THE RIGHTS OF ANY PERSON.
11. Indemnification.
Licensee will defend De Labs against any claim, suit or proceeding
brought by a third party: (i) alleging a breach of this Agreement by
Licensee or (ii) arising from or relating to use of any Licensed
Trademark under this Agreement, including any product liability claim
or any claim of infringement, dilution, or other violation of any
intellectual property rights relating to the manufacture, promotion,
advertising, distribution, or sale of the Licensed Products by
Licensee (but excluding any claim based solely on an allegation that
Licensee’s use of the Licensed Marks in accordance with this Agreement
infringes such third-party’s trademarks). De Labs shall have the
right to defend any such claim through counsel of its own choice. You
may not settle any claim, suit, or proceeding without De Labs’ prior
written consent.
12. Miscellaneous.
- Governing Law; Disputes. This Agreement will be governed by and construed in accordance with
the laws of the State of California without giving effect to any
principles of conflict of laws that would lead to the application of
the laws of another jurisdiction. Any legal action or proceeding
arising under or related to this Agreement will be brought exclusively
in the federal or state courts located in Los Angeles, California and
the parties irrevocably consent to the personal jurisdiction and venue
therein. However, De Labs may seek injunctive relief in any court of
competent jurisdiction to prevent unauthorized use of the Licensed
Marks. In there is any conflict or inconsistency in the application of
this Section 12(a) and dispute resolution procedure in the NFT License
Terms applicable to the DeGods NFT, the dispute language procedure in
such NFT License Terms will prevail.
- Amendments. De Labs reserves the right to clarify or amend this Agreement by
publicly publishing a new version of it. You may not amend this
Agreement without De Labs’ written agreement to do so.
- Miscellaneous. Licensee may not assign or transfer this Agreement, by
operation of law, or otherwise, without De Labs’ prior written
consent. A Change of Control of Licensee will be considered an
assignment of this Agreement. De Labs may freely assign this
Agreement, in whole or in part. Subject to the foregoing, this
Agreement is binding upon and will inure to the benefit of each of the
parties and their respective successors and permitted assigns. All
notices required or permitted under this Agreement will be in writing
and will reference this Agreement. This Agreement is the complete and
exclusive agreement between the parties with respect to its subject
matter and supersedes all prior or contemporaneous agreements,
communications and understandings, both written and oral, with respect
to its subject matter. Either party’s failure to enforce any
provision of this Agreement will not constitute a waiver of future
enforcement of that or any other provision. No waiver of any
provision of this Agreement will be effective unless it is in writing
and signed by the party granting the waiver. Nothing in this
Agreement will be construed to create a partnership, joint venture or
agency relationship between the parties. Neither party will have the
power to bind the other or to incur obligations on the other’s behalf
without such other party’s prior written consent. Unless otherwise
expressly provided, no provisions of this Agreement are intended or
will be construed to confer upon or give to any person or entity,
other than De Labs and Licensee, any rights, remedies or other
benefits under or by reason of this Agreement. If any provision of
this Agreement is held invalid, illegal or unenforceable, that
provision will be enforced to the maximum extent permitted by law,
given the fundamental intentions of the parties, and the remaining
provisions of this Agreement will remain in full force and effect.
The headings (and explanatory notes) to sections of this Agreement are
for convenience or reference only and do not form a part of this
Agreement and will not in any way affect their interpretation. The
parties agree to contract electronically and that electronic
signatures will have the same weight and effect as originals.